Development of Capsule containing Immediate Release Tablet and Extended Release Floating Tablet for Monitoring Release of Atenolol

Atenolol is beta blocker absorbed through GIT use for heart diseases. Single tablets, floating tablets and sustained released formulations studied are insufficient to produce effective dose to enhance bioavailability and effectiveness. Our study is focused on development of capsule dosage form conta...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Research journal of pharmacy and technology 2021-04, Vol.14 (4), p.2216-2220
Hauptverfasser: Kolhe, Mahesh Hari, Gilhotra, Ritu Mehra, Asane, Govind Sarangdhar
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 2220
container_issue 4
container_start_page 2216
container_title Research journal of pharmacy and technology
container_volume 14
creator Kolhe, Mahesh Hari
Gilhotra, Ritu Mehra
Asane, Govind Sarangdhar
description Atenolol is beta blocker absorbed through GIT use for heart diseases. Single tablets, floating tablets and sustained released formulations studied are insufficient to produce effective dose to enhance bioavailability and effectiveness. Our study is focused on development of capsule dosage form containing immediate release (IR) and floating extended release (ER) tablets for monitoring release of atenolol in single dosage form. Two different tablets for IR and ER were prepared in three different combinations (Batch). Pre-formulation and post formulation parameters found to be within acceptable limits of formulation. Release behavior of individual tablets and capsule containing two tablets were studied. Among the batches, capsules containing smaller amount of atenolol in IR and large amount of Atenolol in ER (batch II) showed impressive drug release pattern. This formulation was stable even after a month and achieved optimum release behavior of immediate release and sustained release. This study could be used for effective treatment for different heart complications and reduce toxicity due to high plasma concentration in increased dose frequency.
doi_str_mv 10.52711/0974-360X.2021.00393
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_2533806935</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2533806935</sourcerecordid><originalsourceid>FETCH-LOGICAL-c196t-2cb0f8ac3b78e8980bfadcd1e1c6521f274712087af57fca6fe19c21f1b2ec3a3</originalsourceid><addsrcrecordid>eNo9kF9LwzAUxYMoOOY-ghDwuTN_1jZ9HHPTwUSQCb6FNL2RjrSpSSb66ie33ebuy72ce8698EPolpJpynJK70mRzxKekfcpI4xOCeEFv0Cjs3x5nqm4RpMQdqSvTKRsJkbo9wG-wLqugTZiZ_BCdWFvAWvXRlW3dfuB100DVa0i4FewoALgrSotRKzaCi-_I7QVVOfdyjoVh9jJZJzHz66to_OD-m_rX837pLPO3qAro2yAyamP0dtquV08JZuXx_Vivkk0LbKYMF0SI5TmZS5AFIKURlW6okB1ljJqWD7LKSMiVybNjVaZAVrofkFLBporPkZ3x7udd597CFHu3N63_UvJUs4FyQqe9q706NLeheDByM7XjfI_khJ5IC4HnHJAKwfi8kCc_wGACXXv</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2533806935</pqid></control><display><type>article</type><title>Development of Capsule containing Immediate Release Tablet and Extended Release Floating Tablet for Monitoring Release of Atenolol</title><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Kolhe, Mahesh Hari ; Gilhotra, Ritu Mehra ; Asane, Govind Sarangdhar</creator><creatorcontrib>Kolhe, Mahesh Hari ; Gilhotra, Ritu Mehra ; Asane, Govind Sarangdhar</creatorcontrib><description>Atenolol is beta blocker absorbed through GIT use for heart diseases. Single tablets, floating tablets and sustained released formulations studied are insufficient to produce effective dose to enhance bioavailability and effectiveness. Our study is focused on development of capsule dosage form containing immediate release (IR) and floating extended release (ER) tablets for monitoring release of atenolol in single dosage form. Two different tablets for IR and ER were prepared in three different combinations (Batch). Pre-formulation and post formulation parameters found to be within acceptable limits of formulation. Release behavior of individual tablets and capsule containing two tablets were studied. Among the batches, capsules containing smaller amount of atenolol in IR and large amount of Atenolol in ER (batch II) showed impressive drug release pattern. This formulation was stable even after a month and achieved optimum release behavior of immediate release and sustained release. This study could be used for effective treatment for different heart complications and reduce toxicity due to high plasma concentration in increased dose frequency.</description><identifier>ISSN: 0974-3618</identifier><identifier>EISSN: 0974-360X</identifier><identifier>EISSN: 0974-306X</identifier><identifier>DOI: 10.52711/0974-360X.2021.00393</identifier><language>eng</language><publisher>Raipur: A&amp;V Publications</publisher><subject>Bioavailability ; Drug dosages ; Heart rate</subject><ispartof>Research journal of pharmacy and technology, 2021-04, Vol.14 (4), p.2216-2220</ispartof><rights>Copyright A&amp;V Publications Apr 2021</rights><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c196t-2cb0f8ac3b78e8980bfadcd1e1c6521f274712087af57fca6fe19c21f1b2ec3a3</citedby><cites>FETCH-LOGICAL-c196t-2cb0f8ac3b78e8980bfadcd1e1c6521f274712087af57fca6fe19c21f1b2ec3a3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>315,782,786,27931,27932</link.rule.ids></links><search><creatorcontrib>Kolhe, Mahesh Hari</creatorcontrib><creatorcontrib>Gilhotra, Ritu Mehra</creatorcontrib><creatorcontrib>Asane, Govind Sarangdhar</creatorcontrib><title>Development of Capsule containing Immediate Release Tablet and Extended Release Floating Tablet for Monitoring Release of Atenolol</title><title>Research journal of pharmacy and technology</title><description>Atenolol is beta blocker absorbed through GIT use for heart diseases. Single tablets, floating tablets and sustained released formulations studied are insufficient to produce effective dose to enhance bioavailability and effectiveness. Our study is focused on development of capsule dosage form containing immediate release (IR) and floating extended release (ER) tablets for monitoring release of atenolol in single dosage form. Two different tablets for IR and ER were prepared in three different combinations (Batch). Pre-formulation and post formulation parameters found to be within acceptable limits of formulation. Release behavior of individual tablets and capsule containing two tablets were studied. Among the batches, capsules containing smaller amount of atenolol in IR and large amount of Atenolol in ER (batch II) showed impressive drug release pattern. This formulation was stable even after a month and achieved optimum release behavior of immediate release and sustained release. This study could be used for effective treatment for different heart complications and reduce toxicity due to high plasma concentration in increased dose frequency.</description><subject>Bioavailability</subject><subject>Drug dosages</subject><subject>Heart rate</subject><issn>0974-3618</issn><issn>0974-360X</issn><issn>0974-306X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNo9kF9LwzAUxYMoOOY-ghDwuTN_1jZ9HHPTwUSQCb6FNL2RjrSpSSb66ie33ebuy72ce8698EPolpJpynJK70mRzxKekfcpI4xOCeEFv0Cjs3x5nqm4RpMQdqSvTKRsJkbo9wG-wLqugTZiZ_BCdWFvAWvXRlW3dfuB100DVa0i4FewoALgrSotRKzaCi-_I7QVVOfdyjoVh9jJZJzHz66to_OD-m_rX837pLPO3qAro2yAyamP0dtquV08JZuXx_Vivkk0LbKYMF0SI5TmZS5AFIKURlW6okB1ljJqWD7LKSMiVybNjVaZAVrofkFLBporPkZ3x7udd597CFHu3N63_UvJUs4FyQqe9q706NLeheDByM7XjfI_khJ5IC4HnHJAKwfi8kCc_wGACXXv</recordid><startdate>20210401</startdate><enddate>20210401</enddate><creator>Kolhe, Mahesh Hari</creator><creator>Gilhotra, Ritu Mehra</creator><creator>Asane, Govind Sarangdhar</creator><general>A&amp;V Publications</general><scope>AAYXX</scope><scope>CITATION</scope><scope>04Q</scope><scope>04S</scope><scope>04W</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope></search><sort><creationdate>20210401</creationdate><title>Development of Capsule containing Immediate Release Tablet and Extended Release Floating Tablet for Monitoring Release of Atenolol</title><author>Kolhe, Mahesh Hari ; Gilhotra, Ritu Mehra ; Asane, Govind Sarangdhar</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c196t-2cb0f8ac3b78e8980bfadcd1e1c6521f274712087af57fca6fe19c21f1b2ec3a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Bioavailability</topic><topic>Drug dosages</topic><topic>Heart rate</topic><toplevel>online_resources</toplevel><creatorcontrib>Kolhe, Mahesh Hari</creatorcontrib><creatorcontrib>Gilhotra, Ritu Mehra</creatorcontrib><creatorcontrib>Asane, Govind Sarangdhar</creatorcontrib><collection>CrossRef</collection><collection>India Database</collection><collection>India Database: Business</collection><collection>India Database: Science &amp; Technology</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><jtitle>Research journal of pharmacy and technology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kolhe, Mahesh Hari</au><au>Gilhotra, Ritu Mehra</au><au>Asane, Govind Sarangdhar</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Development of Capsule containing Immediate Release Tablet and Extended Release Floating Tablet for Monitoring Release of Atenolol</atitle><jtitle>Research journal of pharmacy and technology</jtitle><date>2021-04-01</date><risdate>2021</risdate><volume>14</volume><issue>4</issue><spage>2216</spage><epage>2220</epage><pages>2216-2220</pages><issn>0974-3618</issn><eissn>0974-360X</eissn><eissn>0974-306X</eissn><abstract>Atenolol is beta blocker absorbed through GIT use for heart diseases. Single tablets, floating tablets and sustained released formulations studied are insufficient to produce effective dose to enhance bioavailability and effectiveness. Our study is focused on development of capsule dosage form containing immediate release (IR) and floating extended release (ER) tablets for monitoring release of atenolol in single dosage form. Two different tablets for IR and ER were prepared in three different combinations (Batch). Pre-formulation and post formulation parameters found to be within acceptable limits of formulation. Release behavior of individual tablets and capsule containing two tablets were studied. Among the batches, capsules containing smaller amount of atenolol in IR and large amount of Atenolol in ER (batch II) showed impressive drug release pattern. This formulation was stable even after a month and achieved optimum release behavior of immediate release and sustained release. This study could be used for effective treatment for different heart complications and reduce toxicity due to high plasma concentration in increased dose frequency.</abstract><cop>Raipur</cop><pub>A&amp;V Publications</pub><doi>10.52711/0974-360X.2021.00393</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0974-3618
ispartof Research journal of pharmacy and technology, 2021-04, Vol.14 (4), p.2216-2220
issn 0974-3618
0974-360X
0974-306X
language eng
recordid cdi_proquest_journals_2533806935
source Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals
subjects Bioavailability
Drug dosages
Heart rate
title Development of Capsule containing Immediate Release Tablet and Extended Release Floating Tablet for Monitoring Release of Atenolol
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-05T17%3A49%3A52IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Development%20of%20Capsule%20containing%20Immediate%20Release%20Tablet%20and%20Extended%20Release%20Floating%20Tablet%20for%20Monitoring%20Release%20of%20Atenolol&rft.jtitle=Research%20journal%20of%20pharmacy%20and%20technology&rft.au=Kolhe,%20Mahesh%20Hari&rft.date=2021-04-01&rft.volume=14&rft.issue=4&rft.spage=2216&rft.epage=2220&rft.pages=2216-2220&rft.issn=0974-3618&rft.eissn=0974-360X&rft_id=info:doi/10.52711/0974-360X.2021.00393&rft_dat=%3Cproquest_cross%3E2533806935%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2533806935&rft_id=info:pmid/&rfr_iscdi=true